![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 85
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 85
Showing 26-50 of 85 citing articles:
A comprehensive analysis of Notch signalling genes in breast cancer: Expression pattern and prognostic significance
Shazia Sofi, Hina Qayoom, Nighat Khaliq, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 6
Shazia Sofi, Hina Qayoom, Nighat Khaliq, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 6
Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy
Catarina Alves-Vale, Ana Maria Capela, Carlota Tavares-Marcos, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 910-924
Open Access | Times Cited: 6
Catarina Alves-Vale, Ana Maria Capela, Carlota Tavares-Marcos, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 910-924
Open Access | Times Cited: 6
Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation
Hina Qayoom, Bader Alshehri, Burhan Ul Haq, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 12, pp. 103848-103848
Open Access | Times Cited: 6
Hina Qayoom, Bader Alshehri, Burhan Ul Haq, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 12, pp. 103848-103848
Open Access | Times Cited: 6
Prognostic significance and expression pattern of glucose related genes in breast cancer: A comprehensive computational biology approach
Bader Alshehri
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 1, pp. 103896-103896
Open Access | Times Cited: 6
Bader Alshehri
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 1, pp. 103896-103896
Open Access | Times Cited: 6
Clinicopathological Significance and Expression pattern of Bcl2 in Breast Cancer: A comprehensive in silico and in vitro Study
Shazia Sofi, Umar Mehraj, Nusrat Jan, et al.
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 2, pp. 103916-103916
Open Access | Times Cited: 6
Shazia Sofi, Umar Mehraj, Nusrat Jan, et al.
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 2, pp. 103916-103916
Open Access | Times Cited: 6
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
Yu Huang, Yali Fan, Ziyi Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12375-12375
Open Access | Times Cited: 5
Yu Huang, Yali Fan, Ziyi Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12375-12375
Open Access | Times Cited: 5
ESCO2’s oncogenic role in human tumors: a pan-cancer analysis and experimental validation
Yue Huang, Dapeng Chen, Yi Bai, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yue Huang, Dapeng Chen, Yi Bai, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Identification of hub genes and pathways in hepatitis B virus‐associated hepatocellular carcinoma: A comprehensive in silico study
Niloufar Sadat Kalaki, Mozhgan Ahmadzadeh, Atena Mansouri, et al.
Health Science Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 1
Niloufar Sadat Kalaki, Mozhgan Ahmadzadeh, Atena Mansouri, et al.
Health Science Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 1
Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis
Hina Qayoom, Sania Bashir, Rumaisa Khan, et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108164-108164
Closed Access | Times Cited: 1
Hina Qayoom, Sania Bashir, Rumaisa Khan, et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108164-108164
Closed Access | Times Cited: 1
Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity
Vineeta Teotia, Prakash Jha, Madhu Chopra
ACS Omega (2024)
Open Access | Times Cited: 1
Vineeta Teotia, Prakash Jha, Madhu Chopra
ACS Omega (2024)
Open Access | Times Cited: 1
Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors
Mohammad Nadeem Lone, Shazia Gul, Umar Mehraj, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 10, pp. 6212-6231
Closed Access | Times Cited: 4
Mohammad Nadeem Lone, Shazia Gul, Umar Mehraj, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 10, pp. 6212-6231
Closed Access | Times Cited: 4
Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process
Yousof Saeedi Honar, Saleh Javaher, Marziye Soleimani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Yousof Saeedi Honar, Saleh Javaher, Marziye Soleimani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy
М. В. Немцова, Ekaterina Kuznetsova, Irina V. Bure
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16961-16961
Open Access | Times Cited: 4
М. В. Немцова, Ekaterina Kuznetsova, Irina V. Bure
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16961-16961
Open Access | Times Cited: 4
Response of Therapy in Cell-Cycle Regulatory Genes in Breast Cancer
Manzoor Ahmad Mir, Shariqa Aisha, Kaneez Fatima, et al.
(2023), pp. 335-353
Closed Access | Times Cited: 3
Manzoor Ahmad Mir, Shariqa Aisha, Kaneez Fatima, et al.
(2023), pp. 335-353
Closed Access | Times Cited: 3
Current Treatment Approaches to Breast Cancer
Manzoor Ahmad Mir, Abrar Yousuf Mir
(2023), pp. 23-51
Closed Access | Times Cited: 3
Manzoor Ahmad Mir, Abrar Yousuf Mir
(2023), pp. 23-51
Closed Access | Times Cited: 3
The Interleukin-8 Pathway in Cancer
Manzoor Ahmad Mir, Mina Rashid, Nusrat Jan
(2023), pp. 165-190
Closed Access | Times Cited: 3
Manzoor Ahmad Mir, Mina Rashid, Nusrat Jan
(2023), pp. 165-190
Closed Access | Times Cited: 3
Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors
Abdullah Almilaibary
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 5
Abdullah Almilaibary
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 5
Introduction to Cell Cycle and Its Regulators
Manzoor Ahmad Mir, Asma Jan
(2023), pp. 53-82
Closed Access | Times Cited: 2
Manzoor Ahmad Mir, Asma Jan
(2023), pp. 53-82
Closed Access | Times Cited: 2
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
Yu Huang, Yali Fan, Ziyi Zhao, et al.
(2023)
Open Access | Times Cited: 2
Yu Huang, Yali Fan, Ziyi Zhao, et al.
(2023)
Open Access | Times Cited: 2
Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis
Saba Manoochehrabadi, Morteza Talebi Doluee, Hossein Pashaiefar, et al.
Blood Research (2024) Vol. 59, Iss. 1
Open Access
Saba Manoochehrabadi, Morteza Talebi Doluee, Hossein Pashaiefar, et al.
Blood Research (2024) Vol. 59, Iss. 1
Open Access
Identification of Potential Phytochemicals Against Cyclin-Dependent Kinase 1 and Cyclin-Dependent Kinase 2: A Molecular Docking and Molecular Dynamic Approach
Swaranjali Pawar, Shalini Shinde, P.B. Chavan, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. 1
Open Access
Swaranjali Pawar, Shalini Shinde, P.B. Chavan, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. 1
Open Access
GC–MS analysis, pharmacokinetic properties, molecular docking and dynamics simulation of bioactives from Curcumis maderaspatanus to target oral cancer
Ronisha Shankar Rao, Deepak Saravanan, Monisha Mohan
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access
Ronisha Shankar Rao, Deepak Saravanan, Monisha Mohan
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access
Transcriptomic analysis and experiments revealed that remimazolam promotes proliferation and G1/S transition in HCT8 cells
Runjia Wang, Shuai Li, Han Hu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Runjia Wang, Shuai Li, Han Hu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
HANSynergy: Heterogeneous Graph Attention Network for Drug Synergy Prediction
Ning Cheng, Li Wang, Yiping Liu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 4334-4347
Closed Access
Ning Cheng, Li Wang, Yiping Liu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 4334-4347
Closed Access
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
Olivia Craig, Sam Lee, Courtney Pilcher, et al.
NAR Genomics and Bioinformatics (2024) Vol. 6, Iss. 3
Open Access
Olivia Craig, Sam Lee, Courtney Pilcher, et al.
NAR Genomics and Bioinformatics (2024) Vol. 6, Iss. 3
Open Access